BioCentury
ARTICLE | Financial News

MetaPhore raises $13 million

December 28, 2000 8:00 AM UTC

MetaPhore (St. Louis, Mo.), a developer of antioxidant metal compounds to treat autoimmune disorders, cancer, pain and inflammation, raised $13 million in a venture financing. Investors included Stife...